Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 661-669 , October 2008

High Mortality Without ESCAPE: The Registry of Heart Failure Patients Receiving Pulmonary Artery Catheters Without Randomization

  • Larry A. Allen, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Joseph G. Rogers, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • Corresponding Author InformationReprint requests: Joseph G. Rogers, MD, Associate Professor of Medicine, Division of Cardiovascular Medicine, Duke University, Box 3034 DUMC, Durham, NC 27710.
    • ,
  • J. Wayne Warnica, MD

      Affiliations

    • Division of Cardiology, Foothills Provincial General Hospital, University of Calgary, Alberta, Canada
    • ,
  • Thomas G. DiSalvo, MD

      Affiliations

    • Cardiology Division, Vanderbilt University, Nashville, Tennessee
    • ,
  • Gudaye Tasissa, PhD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Cynthia Binanay, RN, BSN

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Robert M. Califf, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Carl V. Leier, MD

      Affiliations

    • Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio
    • ,
  • Monica R. Shah, MD

      Affiliations

    • Heart Failure and Cardiac Transplant, Washington Hospital Center, Washington, DC
    • ,
  • Lynne W. Stevenson, MD

      Affiliations

    • Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts
    • ,
  • On Behalf of the ESCAPE Investigators and Coordinators

Received 4 February 2008 ,Revised 29 April 2008 ,Accepted 8 May 2008.

References 

  1. Eisenberg PR, Jaffe AS, Schuster DP. Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients. Crit Care Med. 1984;12:549–553
  2. Swan HJ, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med. 1970;283:447–451
  3. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1–e82
  4. Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D'Alessandro A, Dec GW, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations March 28-29, 2001, Crystal City, Va. Circulation. 2002;106:836–841
  5. Stevenson LW, Tillisch JH. Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation. 1986;74:1303–1308
  6. Stevenson LW, Sietsema K, Tillisch JH, Lem V, Walden J, Kobashigawa JA, et al. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation. 1990;81:78–85
  7. Stevenson LW, Brunken RC, Belil D, Grover-McKay M, Schwaiger M, Schelbert HR, et al. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol. 1990;15:174–180
  8. Steimle AE, Stevenson LW, Chelimsky-Fallick C, Fonarow GC, Hamilton MA, Moriguchi JD, et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation. 1997;96:1165–1172
  9. Connors AF, Speroff T, Dawson NV, Thomas C, Harrell FE, Wagner D, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA. 1996;276:889–897
  10. Shah MR, O'Connor CM, Sopko G, Hasselblad V, Califf RM, Stevenson LW. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (ESCAPE): design and rationale. Am Heart J. 2001;141:528–535
  11. The Escape Investigators and Escape Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294:1625–1633
  12. Shah MR, Hasselblad V, Stevenson LW, Binanay C, O'Connor CM, Sopko G, et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA. 2005;294:1664–1670
  13. Wiener RS, Welch HG. Trends in the use of the pulmonary artery catheter in the United States, 1993-2004. JAMA. 2007;298:423–429
  14. National Death IndexNational Center for Health Statistics, Centers for Disease Control. Available at: http://www.cdc.gov/nchs/ndi.htm. Accessed January 23, 2007.
  15. National Death Index User's Manual. Hyattsville, MD: Department of Vital Statistics, Centers for Disease Control; 2003;
  16. Elkayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, et al. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J. 2007;153:98–104
  17. Kennedy JW, Kaiser GC, Fisher LD, Fritz JK, Myers W, Mudd JG, et al. Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation. 1981;63:793–802
  18. Feit F, Brooks MM, Sopko G, Keller NM, Rosen A, Krone R, et al. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation. 2000;101:2795–2802
  19. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, et al. Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J Am Coll Cardiol. 2000;36:1063–1070
  20. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–2575
  21. Drazner M, Yancy C, Shah M, Nohria A, Leier C, Miller L, et al. Utility of the history and physical examination in assessing hemodynamics in patients with advanced heart failure: The ESCAPE trial. Circulation. 2005;112:640
  22. Yamokoski LM, Hasselblad V, Moser DK, Binanay C, Conway GA, Glotzer JM, et al. Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial. J Card Fail. 2007;13:8–13
  23. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46:57–64

 The ESCAPE registry was funded in part by an unrestricted grant from Edwards LifeSciences. The ESCAPE trial and overall program were primarily supported by contract N01-HV-98177 from the National Heart, Lung, and Blood Institute.

PII: S1071-9164(08)00168-1

doi: 10.1016/j.cardfail.2008.05.004

Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 661-669 , October 2008

Article Tools

* Image Usage & Resolution